FDA panel could soon expand COVID-19 vaccine access to kids
A FDA panel met Tuesday to consider allowing the Moderna COVID-19 vaccine for children ages 6-17. Officials are also considering authorizing the Pfizer vaccine for children 6 months - 5 years. Elise Preston reports. (6/14/22)